Bone Marrow Mast Cell Morphologic Features and Hematopoietic Dyspoiesis in Systemic Mast Cell Disease
Open Access
- 1 August 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 116 (2) , 177-182
- https://doi.org/10.1309/q2wj-46cl-yrft-m5jf
Abstract
Systemic mast cell disease (SMCD) cannot be distinguished from reactive mastocytosis (RM) by quantitation of mast cells in aspirate smears, and few sKeywords
This publication has 19 references indexed in Scilit:
- The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997Laboratory Investigation, 2000
- Recent Advances in Mastocytosis ResearchInternational Archives of Allergy and Immunology, 1999
- Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.Proceedings of the National Academy of Sciences, 1995
- Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosisThe American Journal of Medicine, 1991
- Systemic Mast Cell DiseaseMedicine, 1988
- Tissue mast cells in health and diseasePathology - Research and Practice, 1985
- Systemic mastocytosisThe American Journal of Surgical Pathology, 1983
- Increased Bone Marrow Mast Cells in Preleukemic Syndromes, Acute Leukemia, and Lymphoproliferative DisordersAmerican Journal of Clinical Pathology, 1981
- Bone-Marrow Mast Cells in Lymphoproliferative DisordersAnnals of Internal Medicine, 1978
- Mast cell infiltrates of the skin and the mastocytosis syndromeHuman Pathology, 1973